We will own iPSC* regenerative medicine
products, services and technologies, the
building block for a variety of human cells
and tissue models for science, drug
discovery, toxicology and therapy *induced Pluripotent Stem Cell
A growing team will complete a BIRAC
funded project realizing a novel cell
culture medium platform replacing
proteins with chemical compounds. This
capability will enable development of
affordable cell lines capable of meeting
future therapeutic demands for safe stem
cells plus provide research tools for a
growing cellular ecosystem in India.
Cellagility Biomed has the capability to deliver a highly optimised safety
service, externally benchmarked with audited assurance. A guarantee of our
Safe-iPSC potential for future clinical use. If you are looking for alternative
solutions for your product development and research, talk to our cell
engineers for the latest in human cell sourcing tools and culture media.
Cellagility Biomed founded in 2018,
incubated at the Bangalore
Bioinnovation Centre has expanded
collaboration to include both C-Camp,
Centre for Cellular and Molecular
Platforms and IKP Knowledge Parks.
This vibrant community is further
strengthened through our partnership
with SDM Medical College and the
Central Research Laboratory’s excellent
iPSC cell banking facility.